Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Schrodinger in Collaboration with Thermo Fisher Scientific

share with twitter share with LinkedIn share with facebook
06/23/2020 | 07:44am EDT

By Michael Dabaie

 

Schrodinger Inc. said it is in a strategic collaboration with Thermo Fisher Scientific to extend the use of cryo-electron microscopy in connection with in silico compound screening to accelerate drug discovery.

The collaboration uses Schrodinger's software platform with Thermo Fisher's cryo-EM technology to expand the applicability of structure-based drug discovery to a wider array of targets. Schrodinger provides a computational platform to accelerate drug discovery and materials design.

Schrodinger said it will identify drug discovery targets and Thermo Fisher will obtain cryo-EM structures of these targets. Schrodinger said it will then use its computational platform to identify development candidates.

Schrodinger shares were up 3% to $78.00 in premarket trading. Thermo Fisher was up 1.3% to $356.63.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
SCHRÖDINGER, INC. -1.13% 71.17 Delayed Quote.0.00%
THERMO FISHER SCIENTIFIC -0.34% 414.33 Delayed Quote.27.54%
share with twitter share with LinkedIn share with facebook
Latest news on THERMO FISHER SCIENTIFIC
08/07THERMO FISHER SCIENTIFIC : Accelerates Nanometer-Scale Research with Next-Genera..
AQ
08/07THERMO FISHER SCIENTIFIC : Versatile Thermo Scientific Helios 5 PFIBs Enable Mat..
AQ
08/06Davidson Kempner says again it will not be tendering Qiagen shares
RE
08/06Davidson Kempner says again it will not be tendering Qiagen shares
RE
08/05THERMO FISHER SCIENTIFIC : 's COVID-19 Response Continues to Expand with New Hig..
PR
08/05The Global pH Sensors & Analyzers Market to Garner $1939.5 Million by 2028
AQ
08/04THERMO FISHER SCIENTIFIC INC. : Other Events, Financial Statements and Exhibits ..
AQ
08/04THERMO FISHER SCIENTIFIC : Confirms Offer to Acquire QIAGEN Shares Expires on Au..
PR
08/04THERMO FISHER SCIENTIFIC : OIE Approves Registration of VetMAX African Swine Fev..
AQ
08/03THERMO FISHER SCIENTIFIC : China Approves Thermo Fisher Scientific's African Swi..
PU
More news
Financials (USD)
Sales 2020 28 041 M - -
Net income 2020 4 456 M - -
Net Debt 2020 12 658 M - -
P/E ratio 2020 37,0x
Yield 2020 0,21%
Capitalization 164 B 164 B -
EV / Sales 2020 6,30x
EV / Sales 2021 5,92x
Nbr of Employees 75 000
Free-Float 90,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 442,72 $
Last Close Price 414,33 $
Spread / Highest target 20,7%
Spread / Average Target 6,85%
Spread / Lowest Target -34,6%
EPS Revisions
Managers
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC27.54%163 905
DANAHER CORPORATION33.83%145 713
INTUITIVE SURGICAL, INC.16.02%80 262
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.79.97%57 118
BOSTON SCIENTIFIC CORPORATION-13.82%55 753
ILLUMINA, INC.7.21%52 282